The role of serotonin in the control of cerebral activity: studies with intracerebral 5,7-dihydroxytryptamine

Effects of p-chlorophenylalanine and scopolamine on retention of habits in rats

Rats were trained on a conventional maze test or on a swim-to-platform test. Retention of swim-to-platform performance 7 days later was severely impaired by posttraining treatment with a combination of p-chlorophenylalanine (PCPA) and scopolamine although neither drug alone had any effect. Retention of the maze habit was moderately impaired by scopolamine alone and severely impaired by a combination of scopolamine and PCPA, but was unaffected by PCPA alone. Polygraphic recordings confirmed previous reports that a combination of PCPA and scopolamine can abolish neocortical low voltage fast activity and hippocampal rhythmical slow activity. Combined blockade of central cholinergic and serotonergic neurotransmission in rats may provide a useful animal model of Alzheimer's disease.

Alterations in acetylcholine release in the rat hippocampus during sleep-wakefulness detected by intracerebral dialysis

Acetylcholine (ACh) release from the dorsal hippocampus was continuously monitored in freely moving rats during a light period using an intracerebral dialysis technique. A dialysate was collected every 6 min and polygraph recordings including cortical and hippocampal electroencephalograms, electromyogram, and electrooculogram were simultaneously made to determine the stage of sleep-wakefulness. The content of ACh was measured by high-performance liquid chromatography with electrochemical detection. ACh output showed profound and state-dependent fluctuations. ACh levels during waking increased approximately 300% compared to slow wave sleep. In contrast, the rate of ACh release during paradoxical sleep was as high as during waking and appeared to be even higher. These results revealed that the intracerebral dialysis technique provides a useful method to monitor changes in spontaneous neurotransmitter release during the sleep-waking cycle.

A general role for serotonin in the control of behavior: studies with intracerebral 5,7-dihydroxytryptamine

Multiple injections of 5,7-dihydroxytryptamine (5,7-DHT) into the rat brainstem reduced forebrain levels of serotonin and 5-hydroxyindoleacetic acid to 3-10% of the levels observed in control rats that had received intrabrainstem injection of a Locke's solution vehicle. This treatment reduced or abolished atropine-resistant cerebral activation (ARCA) in most cases. In rats in which ARCA was impaired or lost, a number of behavioral abnormalities were observed. These included: high levels of locomotion in an open field test; a deficiency in swimming to, and climbing upon, a visible platform in a water-filled tank; deficient social behavior; and impaired performance in a simple test of active avoidance. These deficits were not due to low level motor impairment. The 5,7-DHT-treated rats displayed a circadian rhythm of activity in running wheels. It is proposed that ascending serotonergic projections are an important component in the cerebral control of the Type 1 behavior with which the occurrence of ARCA is closely linked. Since Type 1 behavior includes such motor patterns as walking and manipulation of objects with the limbs, which are essential components of a great variety of behavioral performances, it is to be expected that a loss of ascending serotonergic function will result in a generalized deficit in behavior.